Jiantao Ma1, Caroline S Fox2, Paul F Jacques1, Elizabeth K Speliotes3, Udo Hoffmann4, Caren E Smith1, Edward Saltzman1, Nicola M McKeown5. 1. USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, United States. 2. NHLBI's Framingham Heart Study, Framingham, MA, United States; Harvard Medical School, Boston, MA, United States. 3. University of Michigan Medical School, Ann Arbor, MI, United States. 4. Harvard Medical School, Boston, MA, United States; Massachusetts General Hospital, Boston, MA, United States. 5. USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, United States. Electronic address: nicola.mckeown@tufts.edu.
Abstract
BACKGROUND & AIMS: Non-alcoholic fatty liver disease affects ∼30% of US adults, yet the role of sugar-sweetened beverages and diet soda on these diseases remains unknown. We examined the cross-sectional association between intake of sugar-sweetened beverages or diet soda and fatty liver disease in participants of the Framingham Offspring and Third Generation cohorts. METHODS: Fatty liver disease was defined using liver attenuation measurements generated from computed tomography in 2634 participants. Alanine transaminase concentration, a crude marker of fatty liver disease, was measured in 5908 participants. Sugar-sweetened beverage and diet soda intake were estimated using a food frequency questionnaire. Participants were categorized as either non-consumers or consumers (3 categories: 1 serving/month to <1 serving/week, 1 serving/week to <1 serving/day, and ⩾1 serving/day) of sugar-sweetened beverages or diet soda. RESULTS: After adjustment for age, sex, smoking status, Framingham cohort, energy intake, alcohol, dietary fiber, fat (% energy), protein (% energy), diet soda intake, and body mass index, the odds ratios of fatty liver disease were 1, 1.16 (0.88, 1.54), 1.32 (0.93, 1.86), and 1.61 (1.04, 2.49) across sugar-sweetened beverage consumption categories (p trend=0.04). Sugar-sweetened beverage consumption was also positively associated with alanine transaminase levels (p trend=0.007). We observed no significant association between diet soda intake and measures of fatty liver disease. CONCLUSION: In conclusion, we observed that regular sugar-sweetened beverage consumption was associated with greater risk of fatty liver disease, particularly in overweight and obese individuals, whereas diet soda intake was not associated with measures of fatty liver disease.
BACKGROUND & AIMS:Non-alcoholic fatty liver disease affects ∼30% of US adults, yet the role of sugar-sweetened beverages and diet soda on these diseases remains unknown. We examined the cross-sectional association between intake of sugar-sweetened beverages or diet soda and fatty liver disease in participants of the Framingham Offspring and Third Generation cohorts. METHODS:Fatty liver disease was defined using liver attenuation measurements generated from computed tomography in 2634 participants. Alanine transaminase concentration, a crude marker of fatty liver disease, was measured in 5908 participants. Sugar-sweetened beverage and diet soda intake were estimated using a food frequency questionnaire. Participants were categorized as either non-consumers or consumers (3 categories: 1 serving/month to <1 serving/week, 1 serving/week to <1 serving/day, and ⩾1 serving/day) of sugar-sweetened beverages or diet soda. RESULTS: After adjustment for age, sex, smoking status, Framingham cohort, energy intake, alcohol, dietary fiber, fat (% energy), protein (% energy), diet soda intake, and body mass index, the odds ratios of fatty liver disease were 1, 1.16 (0.88, 1.54), 1.32 (0.93, 1.86), and 1.61 (1.04, 2.49) across sugar-sweetened beverage consumption categories (p trend=0.04). Sugar-sweetened beverage consumption was also positively associated with alanine transaminase levels (p trend=0.007). We observed no significant association between diet soda intake and measures of fatty liver disease. CONCLUSION: In conclusion, we observed that regular sugar-sweetened beverage consumption was associated with greater risk of fatty liver disease, particularly in overweight and obese individuals, whereas diet soda intake was not associated with measures of fatty liver disease.
Authors: Elizabeth K Speliotes; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; James B Meigs; Dushyant V Sahani; Joel N Hirschhorn; Christopher J O'Donnell; Caroline S Fox Journal: Hepatology Date: 2010-06 Impact factor: 17.425
Authors: Maria Maersk; Anita Belza; Hans Stødkilde-Jørgensen; Steffen Ringgaard; Elizaveta Chabanova; Henrik Thomsen; Steen B Pedersen; Arne Astrup; Bjørn Richelsen Journal: Am J Clin Nutr Date: 2011-12-28 Impact factor: 7.045
Authors: Stefanie N Hinkle; Shristi Rawal; Anne Ahrendt Bjerregaard; Thor I Halldorsson; Mengying Li; Sylvia H Ley; Jing Wu; Yeyi Zhu; Liwei Chen; Aiyi Liu; Louise Groth Grunnet; Mohammad L Rahman; Freja Bach Kampmann; James L Mills; Sjurdur F Olsen; Cuilin Zhang Journal: Am J Clin Nutr Date: 2019-07-01 Impact factor: 7.045
Authors: James M Rippe; John L Sievenpiper; Kim-Anne Lê; John S White; Roger Clemens; Theodore J Angelopoulos Journal: Nutr Rev Date: 2017-01 Impact factor: 7.110
Authors: Jibran A Wali; Yen Chin Koay; Jason Chami; Courtney Wood; Leo Corcilius; Richard J Payne; Roman N Rodionov; Andreas L Birkenfeld; Dorit Samocha-Bonet; Stephen J Simpson; John F O'Sullivan Journal: Am J Physiol Endocrinol Metab Date: 2020-07-14 Impact factor: 4.310
Authors: Samir Softic; Jesse G Meyer; Guo-Xiao Wang; Manoj K Gupta; Thiago M Batista; Hans P M M Lauritzen; Shiho Fujisaka; Dolors Serra; Laura Herrero; Jennifer Willoughby; Kevin Fitzgerald; Olga Ilkayeva; Christopher B Newgard; Bradford W Gibson; Birgit Schilling; David E Cohen; C Ronald Kahn Journal: Cell Metab Date: 2019-10-01 Impact factor: 27.287
Authors: R V Shah; V L Murthy; M A Allison; J Ding; M Budoff; A C Frazier-Wood; J A C Lima; L Steffen; D Siscovick; K L Tucker; P Ouyang; S A Abbasi; K Danielson; M Jerosch-Herold; D Mozaffarian Journal: Nutr Metab Cardiovasc Dis Date: 2015-12-29 Impact factor: 4.222